BioInvent International
Vincent Ossipow is the current director at BioInvent International. Prior to this, they held various positions in the private equity sector, as well as in academia. Vincent started their career as a financial analyst at Banque Pictet & Cie SA before moving to the National Cancer Institute (NCI) as a postdoctoral fellow. Vincent then took on a faculty member role at Université de Genève from 2000-2007. In 2007, they became a partner at Sectoral Asset Management where they worked until 2013. Vincent Ossipow has years of experience in biotech, medtech, life science tool, and robotics companies.
Vincent Ossipow has a CFA charterholder from the CFA Institute and a Doctor of Philosophy in Molecular Biology from the University of Geneva. Vincent also has a Certificate in International Finance from Georgetown University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BioInvent International
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.